Cite
MLA Citation
Petri Bono et al.. “Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours.” ESMO open, vol. 5, no. 6, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127571491.0x000016